Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...

Wegovy: sales of weight loss injection more than double - The company said more than 45 million people were now ‘benefitting ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy ... mean weight loss of 22% after ...